Pharma Deals Review, Vol 2005, No 58 (2005)

Font Size:  Small  Medium  Large

Novartis Expands Generics Business

Business Review Editor

Abstract


Novartis acquired HEXAL and 67.7% of Eon Labs. The combined value of the transaction totals over €5.65 B of which €4.35 B in cash is for HEXAL. Novartis is to acquire remaining Eon Labs shares for US$31 per share.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.